Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Amantadine Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 17Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Zydus gains final USFDA tentative approval for Amantadine ER capsule
    Zydus gains final USFDA tentative approval for Amantadine ER capsule

    03 Sep 2024

    // EXPRESSPHARMA

    https://www.expresspharma.in/zydus-gains-final-usfda-approval-for-amantadine-extended-release-capsules-68-5-mg-and-tentative-approval-for-137-mg/

    EXPRESSPHARMA
    03 Sep 2024
    Share Share
    Zydus Lifesciences gets USFDA nod for generic medication
    Zydus Lifesciences gets USFDA nod for generic medication

    29 Aug 2024

    // CONTRACT PHARMA

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-lifesciences-gets-usfda-nod-for-generic-medication/articleshow/112866757.cms

    CONTRACT PHARMA
    29 Aug 2024
    Share Share
    Zydus`s Generics Amantadine Receives Approval in US
    Zydus`s Generics Amantadine Receives Approval in US

    26 Aug 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214897

    FDA
    26 Aug 2024
    Share Share
    Enforcement Report - Week of June 7, 2023
    Enforcement Report - Week of June 7, 2023

    07 Jun 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-7-2023-80553.pdf

    FDA
    07 Jun 2023
    Share Share
    Humanwell's Generic Amantadine Hydrochloride Receives Approval in the U.S.
    Humanwell's Generic Amantadine Hydrochloride Receives Approval in the U.S.

    20 Dec 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214580

    FDA
    20 Dec 2022
    Share Share
    US FDA grants tentative approval to Zydus’s Amantadine extended-release capsules
    US FDA grants tentative approval to Zydus’s Amantadine extended-release capsules

    10 Oct 2022

    // EXPRESS PHARMA

    https://www.expresspharma.in/us-fda-grants-tentative-approval-to-zyduss-amantadine-extended-release-capsules/

    EXPRESS PHARMA
    10 Oct 2022
    Share Share